ArticleKidney international reports2024

Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial.

Jeffrey M Saland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.